返回
Ascletis Pharma Inc.（01672.HK）價格
01672.HK 股價走勢圖
ASCLETIS-B (01672.HK)
Ascletis Pharma Inc.
HK$16.6
0.66%
$0.11
休市： Feb 16, 12:00:00 HKT
關鍵數據
前收市價
$16.42
開盤價
$16.49
當日範圍
$15.8 - $16.8
52週區間
$3.92 - $18.75
交易量
2.2M
平均成交量
5.2M
每股盈餘 (TTM)
-0.30
股息收益率
--
市值
$16.3B
什麼是 ASCLETIS-B？
Ascletis Pharma, Inc. engages in the research and development, production, marketing, and sale of pharmaceutical products. The company is headquartered in Hangzhou, Zhejiang and currently employs 208 full-time employees. The company went IPO on 2018-08-01. The firm focuses on viral diseases, non-alcoholic steatohepatitis (NASH) or primary biliary cholangitis (PBC), and oncology. The firm's product pipeline includes ASC22 for chronic hepatitis B functional cure, ASC10 for respiratory syncytial virus (RSV), ASC22 for human immunodeficiency virus (HIV) functional cure, ASC10 and ASC11 for COVID-19, ASC41 for NASH, ASC42 for PBC, ASC61 for solid tumors, ASC40 for moderate and severe acne, and others. The firm conducts its business in the domestic and overseas markets.
